Originally published byEU-Startups
Alcolase, a Copenhagen-based BioTech startup tackling alcohol intolerance by providing remedies for alcohol flush, today announced a €1.5 million funding round supported by Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and a group of business angels. The company plans to first enter the Singapore market, followed by South Korea, where alcohol intolerance is more […]
The post Copenhagen’s Alcolase secures €1.5 million to develop enzyme-based remedy for alcohol flush appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Microsoft storms RAMPART, adds Clarity to agentic AI safety
12h ago
AI code accelerates production failures and spending, study finds
1d ago
Even Claude agrees: hole in its sandbox was real and dangerous
1d ago
Intel's CEO reveals early hiring challenges as bankruptcy concerns deterred top talent
1d ago
Earlybird raising €500m defence fund with French investor AVP, sources say
5h ago